Thesiss

Two significant limitations of tissue specific replicative adenovirus (TSRAd) for cancer virotherapy are limited target specificity and efficacy. We have developed a TSRAd with a "Double Lock" mechanism to provide tighter transcriptional control. This was accomplished by placing…